Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
1.090
-0.040 (-3.54%)
At close: Jan 9, 2026, 4:00 PM EST
1.070
-0.020 (-1.83%)
After-hours: Jan 9, 2026, 6:26 PM EST

Citius Oncology Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Jan '26 Sep '25 Sep '24 Sep '23 Sep '22
921709996-
Market Cap Growth
32.27%71.05%2.93%--
Enterprise Value
92173---
Last Close Price
1.092.031.3910.77-
PB Ratio
2.033.782.153.77-
P/TBV Ratio
2.063.782.153.77-
P/OCF Ratio
--784.41--
Debt / Equity Ratio
0.090.090.08--
Quick Ratio
0.080.080--
Current Ratio
0.560.560.340.370.46
Return on Equity (ROE)
-54.42%-54.42%-59.01%-41.09%-
Return on Assets (ROA)
-15.87%-15.87%-19.47%-16.76%-
Return on Capital (ROIC)
-29.82%-29.82%-34.07%-24.52%-
Return on Capital Employed (ROCE)
-45.70%-45.70%-39.80%-45.40%-26.40%
Earnings Yield
-26.79%-14.61%-21.34%-13.19%-
Buyback Yield / Dilution
-7.66%-7.66%-0.82%-100.00%-
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q